Xenetic Biosciences and Periness Enter Clinical Study Agreement to Advance DNase 1 Platform for Large B-Cell Lymphoma Treatment
Xenetic Biosciences, Inc., a biopharmaceutical company pioneering in immuno-oncology, has entered into a clinical study agreement with Periness Ltd. to […]








